British marathon runner Josh Griffiths has received a three-month suspension following a positive drug test after the 2026 Belfast City Marathon. The 33-year-old Welsh athlete tested positive for benzoylecgonine, a metabolite produced when the body processes cocaine, prompting an investigation by the Athletics Integrity Unit (AIU).

The Josh Griffiths doping ban 2026 has attracted attention because of his previous achievements representing Great Britain at the World Athletics Championships and Wales at the Commonwealth Games. Griffiths denied knowingly consuming cocaine or any other recreational drug but was unable to establish how the substance entered his system.

The AIU accepted that any ingestion had taken place outside competition and was unrelated to sport. However, the organisation still imposed a three-month suspension after confirming an anti-doping rule violation.

Griffiths accepted the finding and the sanction. His suspension began on June 19, 2026, and his competition results from May 3 until the end of the ban were also disqualified.

Josh Griffiths positive drug test: What happened after Belfast Marathon?

The Josh Griffiths positive drug test followed the Belfast City Marathon on May 3, 2026. The Welsh runner provided urine samples after the race, and laboratory analysis detected benzoylecgonine in both samples.

Benzoylecgonine is a substance formed when the body breaks down cocaine. Its detection can lead to an anti-doping violation, even if an athlete denies knowingly taking the drug.

According to the AIU investigation, Griffiths was shocked when he was informed about the initial adverse analytical finding. He reportedly described the result as “absolutely impossible” and suggested that there must have been a mistake.

The athlete maintained that he had never knowingly consumed cocaine. He also denied using other social drugs and said he had no knowledge of anyone close to him taking cocaine before the Belfast race.

During the investigation, Griffiths provided details about his activities and movements in the days leading up to the marathon. He also explained his stay at the official race hotel.

He stressed that he had not attended social events or consumed alcohol. His interactions had mainly involved fellow athletes and race officials.

Despite presenting his explanation, Griffiths could not establish exactly how benzoylecgonine entered his body.

Josh Griffiths benzoylecgonine explained: Why did the AIU impose a ban?

An important part of the Josh Griffiths cocaine metabolite test case was determining the circumstances surrounding the substance’s presence in his body.

Benzoylecgonine is a metabolite produced after cocaine enters the body. It is used in testing to identify cocaine exposure and can be detected in urine after the original drug has been metabolised.

During the Josh Griffiths AIU investigation, the athlete submitted scientific information to support his argument that any ingestion had occurred outside competition.

The AIU accepted that the ingestion was out of competition and unrelated to sporting performance. This distinction was relevant when determining the appropriate sanction.

However, acceptance of the out-of-competition circumstances did not mean that Griffiths was cleared of the anti-doping violation.

The presence of the metabolite in both urine samples remained the basis of the case. Griffiths subsequently accepted the anti-doping rule violation and the three-month suspension.

His ban ran from June 19 to September 19, 2026, with the race results affected from May 3 until the conclusion of the suspension.

Josh Griffiths Belfast Marathon disqualification explained

The Josh Griffiths Belfast Marathon disqualification was another major consequence of the AIU decision.

Griffiths had finished fourth at the 2026 Belfast City Marathon, but his result was subsequently expunged under the anti-doping sanction.

His competition results from May 3 until the end of the three-month suspension were also disqualified.

The decision affected his official competitive record and meant that the Belfast Marathon standings and associated prize allocations had to be adjusted.

The case demonstrates that a short suspension can have consequences beyond the period during which an athlete is prohibited from competing. Previous results within the relevant disqualification period can also be removed.

Although Griffiths completed his suspension in September, the impact of the ruling remains an important part of his 2026 season.

Josh Griffiths World Athletics Championships journey

Before the positive drug test controversy, Griffiths had built an impressive reputation in British distance running.

His breakthrough came at the 2017 London Marathon, where he surprised the athletics community by finishing as the fastest British runner while competing as a club athlete.

The Josh Griffiths 2017 London Marathon performance earned him a place in Great Britain’s squad for the 2017 World Athletics Championships.

It was a remarkable achievement for a runner who had not entered the event with the same profile as many established international competitors.

Following that success, Griffiths turned professional and continued developing his marathon career.

He later represented Great Britain at the 2022 World Athletics Championships, adding another major international appearance to his record.

Griffiths also represented Wales at the 2018 Commonwealth Games, competing on a major international stage against leading distance runners.

Another notable performance came at the 2021 London Marathon, where he secured an eighth-place finish.

His journey from club runner to international athlete made him a recognised name in British marathon running. The latest AIU decision has therefore become a significant development in a career that previously attracted attention for its sporting achievements.

Why was Josh Griffiths banned despite denying cocaine use?

The central question surrounding the Josh Griffiths three-month suspension is why the athlete received a ban despite consistently denying knowingly taking cocaine.

The answer lies in the distinction between an athlete’s explanation and the anti-doping violation established through testing.

Griffiths maintained that he had never knowingly consumed the substance. However, he could not prove how benzoylecgonine entered his system.

The AIU accepted that any ingestion was unrelated to sport and occurred outside competition, but the positive findings still resulted in an anti-doping rule violation.

Following the investigation and hearing, Griffiths accepted the sanction rather than continuing to contest the finding.

His three-month suspension has now been completed, but the disqualification of his affected competition results remains part of the case.

The incident is another reminder of the strict responsibilities athletes face under anti-doping regulations. Even when a substance is detected outside competition, the circumstances and applicable rules determine the consequences.

For Griffiths, the ruling represents a difficult chapter following years of progress in British athletics.

Stay tuned with ROKOCRICKET for the latest international sports news, athletics updates, cricket stories and major developments from the world of sport. Subscribe to ROKOCRICKET to stay updated with the biggest sporting headlines.